Solara Active Pharma Sciences Limited has informed the exchange regarding the approval and adoption of the Board Evaluation Policy and amendment to Whistle Blower Policy
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Solara Active Pharma Sciences Limited's Board of Directors, at their meeting on May 15, 2026, adopted a Board Evaluation Policy in compliance with SEBI Listing Regulations. The company also amended its Whistle Blower Policy to incorporate necessary revisions aligned with applicable regulatory requirements. Both updated policies are now available on the company's investor relations section of their website. This filing is a routine governance compliance update under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations.
This announcement has no direct financial impact on shareholders or stock price. It represents standard corporate governance compliance, with the Board Evaluation Policy ensuring systematic assessment of board effectiveness and the updated Whistle Blower Policy strengthening mechanisms for reporting unethical practices.